Abstract
The effect of treatment of an existing neuropathy in streptozocin-induced diabetic rats with the ACTH4–9 analogue ORG 2766 was examined. Four groups of rats were studied: group 1 consisted of age-matched, non-diabetic controls and groups 2, 3 and 4 of diabetic rats. Sensory and motor nerve conduction velocity (SNCV and MNCV) were measured at weeks 0, 4, 6, 8 and 10. Four weeks after the administration of streptozocin (STZ) all diabetic rats showed a significant slowing of SNCV and MNCV. Treatment was then started: group 2 was treated with placebo, group 3 with a low dos (1 μg) of ACTH4–9 subcutaneously every 48h, and group 4 with a high dos (10 μg) of ACTH4–9 subcutaneously every 48 h. The animals treated with the high peptide dosage showed a significant improvement in both SNCV and MNCV from week 6 onwards, whereas this beneficial effect was not demonstrated for the rats treated with the low dosage. This study demonstrates that the ACTH4–9 analogue ORG 2766 can ameliorate existing diabetic neuropathy in STZ-induced diabetic rats.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Greene DA, DeJesus PV Jr, Winegrad AI, Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest 55:1326–1336, 1975
Sima AAF, Zhang WX, Tze WJ, Tai J, Nathaniel V, Diabetic neuropathy in STZ-induced diabetic rats and effect of allogeneic islet cell transplantation. Diabetes 37:1129–1136, 1988
Greene DA, Lattimer DA, Impaired rat sciatic nerve sodium-potassium ATPase activity in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72:1058–1063, 1983
Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA, Polyol pathway activity and myo-inositol metabolism: a suggested relationship in pathogenesis of diabetic neuropathy. Diabetes 32:988–992, 1983
Tuck RR, Schmelzer JD, Low PA, Endoneurial blood flow and oxygen tension in sciatic nerves of rats with experimental diabetic neuropathy. Brain 107:935–950, 1984
Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK, Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 81:6894–6898, 1984
Low PA, Schmelzer JD, Ward KK, Yao JK, Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 250:E94–99, 1986
Low PA, Nickander KK, Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40:873–877, 1991
Vlassara H, Brownlee M, Cerami A, Excessive non-enzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 32:670–674, 1983
Brownlee MB, Cerami A, Vlassara H, Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321, 1988
Tomlinson DR, Moriarty RJ, Mayer JH, Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor sorbinil. Diabetes 33:470–476, 1984
De Koning P, Neijt JP, Jennekens FGI, Gispen WH, ORG 2766 protects from cisplatinin-induced neurotoxicity in rats. Exp Neurol 97:746–750, 1987
Gerritsen van der Hoop R, De Koning P, Boven E, Neijt JP, Jennekens FGI, Gispen WH, Efficacy of the neuropeptide ORG 2766 in the prevention and treatment of cis-platinin-induced neurotoxicity in rats. Eur J Cancer Clin Oncol 24:637–642, 1988
Gerritsen van der Hoop R, Vecht CJ, Van den Burg MEL, Haanstra W, Boogerd W, ten Bokkel Huinink W, Heijmans JJ, Vermorken J, Jennekens FGI, Van Houwelingen JC, Gispen WH, Neijt JP, Prevention of cisplatinin neurotoxicity with an ACTH(4–9) analogue in patients with ovarian cancer. N Engl J Med 322:89–94, 1990
Van der Zee CEEM, Gerritsen van der Hoop R, Gispen WH, Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozotocin-induced diabetic rats. Diabetes 38:225–230, 1989
Bravenboer, Kappelle AC, Hamers FPT, Buren T van, Erkelens DW, Gispen WH, Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 35:813–817, 1992
Waxman SG, Determination of conduction velocity in myelinated nerve fibres. Muscle Nerve 3:141–150, 1980
Stanley EF, Sensory and motor nerve conduction velocities and the latency of the H-reflex during growth of the rat. Exp Neurol 71:497–506, 1981
Fleiss JL, The design and analysis of clinical experiments. Wiley, New York, 1986
Kim J, Kyriazi H, Greene DA, Normalization of Na+−K+-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myoinositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes 40:558–567, 1991
Sonobe M, Yasuda H, Hisanaga T, Maeda K, Yamashita M, Kawabata T, Kikkawa R, Taiguchi Y, Shigeta Y, Amelioration of nerve Na+-analogue OP-1206. α-CD in streptozocin-induced diabetic rats. Diabetes 40:726–730, 1991
Gispen WH, Therapeutical potential for melanocortins in peripheral nerve disease. Trends Pharmacol Sci 11:221–222, 1990
De Koning P, Gispen WH, Org 2766 improves functional and electophysiological aspects of regenerating sciatic nerve in the rat. Peptides 8:415–422, 1987
De Koning P, Verhaagen J, Sloot W, Jennekens FGI, Gispen WH, ORG 2766 stimulated collateral sprouting in rat soleus muscle following partial denervation. Muscle Nerve 12:353–359, 1989
Bravenboer B, Kappelle AC, Buren T van, Erkelens DW, Gispen WH, ACTH4–9-analogue ORG 2766 improves existing diabetic neuropathy in theBB/Wor model. Diabetes 41 [Suppl 1]: A491, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bravenboer, B., Kappelle, A.C., van Buren, T. et al. ACTH4–9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats. Acta Diabetol 30, 21–24 (1993). https://doi.org/10.1007/BF00572869
Issue Date:
DOI: https://doi.org/10.1007/BF00572869